Jefferies Maintains a 'Hold' on Stryker (SYK); Medtech Debate at Analyst Meeting
Get Alerts SYK Hot Sheet
Price: $339.21 -0.55%
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies maintains a 'Hold' on Stryker (NYSE: SYK) price target of $54.00.
Analyst, Raj Denhoy, said, "Stryker’s analyst meeting was in part an illustration of the debate in large cap medtech: with growth slowing, is the best use of cash to increase shareholder value through investment or simply returning it in increasingly larger chunks to holders? Stryker remains in the camp that there are brighter days ahead and investment is still its preferred use. We remain less optimistic on growth picking up appreciably and remain at Hold."
For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.
Shares of Stryker closed at $54.19 yesterday.
Analyst, Raj Denhoy, said, "Stryker’s analyst meeting was in part an illustration of the debate in large cap medtech: with growth slowing, is the best use of cash to increase shareholder value through investment or simply returning it in increasingly larger chunks to holders? Stryker remains in the camp that there are brighter days ahead and investment is still its preferred use. We remain less optimistic on growth picking up appreciably and remain at Hold."
For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.
Shares of Stryker closed at $54.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Downgrades Stryker (SYK) to Peerperform
- Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
- McGraw Hill (MH) PT Raised to $15 at UBS
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share